Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
NOCILQ4 FY26Chemicals & Petrochemicals
Home/Stocks/NOCIL/Q4 FY26

NOCIL Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹162P/E: 40.1Market Cap: ₹2.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

N/A

Fundraise

No

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • →NOCIL targets double-digit volume growth for FY '27 and FY '28. (Page 18)
  • →Volume growth momentum picked up in H2 FY '26, expected to continue into FY '27. (Page 6)
  • →New plant expansions and customer approvals anticipated to drive volume increase, with material capacity utilization improvements expected 6-8 months post-sample submission. (Page 14)
  • →New products are in a pickup phase in FY '27; meaningful volume contribution expected gradually toward year-end. (Page 14)
  • →Export volumes, especially in the USA market, are recovering post-duty adjustments, supporting growth. (Page 14)
  • →Domestic market demand growth expected to be around 7%, supported by tyre industry growth, with cautious supply chain management. (Page 16)
  • →Growth expected to be supported by product mix improvements, cost efficiencies, and geographical expansion. (Pages 16 & 17)

Margin guidance

  • →NOCIL targets double-digit volume growth for FY '27 and FY '28. (Page 18)
  • →The company aims to improve EBITDA margins by approximately 150 basis points from FY '26 levels through operational efficiencies and cost measures. (Page 14)
  • →New product volumes are expected to pick up progressively in FY '27, with a more significant impact towards year-end, aiding volume growth though the exact contribution is uncertain. (Page 14)
  • →Expansion projects including a Rs.130 crore capex and Rs.250 crore Dahej plant expansion are expected to increase merchant sales volumes and improve operating leverage. (Pages 13 & 7)
  • →The operating leverage from volume growth and new capacities should positively impact profits and margins. (Page 14 & 12)
  • →No expected reduction in tax rates for FY '27; normal tax rates anticipated. (Page 18)
  • →Margin improvement expected even if antidumping duty protection is not materialized, via mix, efficiency, specialty growth, and geographic expansion. (Page 14 & 18)

3 more insights locked — sign up free to unlock

Fundraise plans

No
  • →As of FY '26, NOCIL Limited has not borrowed any debt, although it has secured bank lines above Rs.100 crores available for utilization when needed.
  • →The cost of debt, if utilized, will be linked to repo rates.
  • →The company currently has Rs.220 crores of Capital Work In Progress (CWIP), but no project debt has been drawn yet.
  • →Regarding future capex, including the announced Rs.130 crores brownfield expansion, and Rs.250 crores Dahej expansion, financing largely comes from internal working capital efficiencies rather than external debt.
  • →There was no mention of any plans for equity fundraising or additional debt in the near term during this period.
  • →The company remains focused on managing operations and capex through internal cash flows and working capital optimization.

Order book

The transcript provided does not explicitly mention details about the current or expected order book or pending orders for NOCIL Limited as of May 8, 2026. The discussion primarily focuses on: - Volume growth targets for FY '27 and FY '28 at double-digit levels. - Capacity expansions and related capex projects at Dahej. - Market conditions, pricing, import dynamics, antidumping duties, and supply chain issues. - Operational metrics like volumes achieved, margins, and financial performance. - No specific mention or data on order backlog or pending order status is available in the given pages. Hence, no concrete information on current or expected order book or pending orders can be provided from the transcript.

Capex plans

Yes
  • →Rs.130 crores capex focused largely on specialty segment, expected to be commissioned by FY '28, aiming to increase specialty product mix from ~15% to 20%. (Page 17)
  • →Rs.250 crores capex at Dahej for incremental capacity expansion, increasing capacity by roughly 20%, targeting merchant sales. (Page 8 & 17)
  • →The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. (Page 8)
  • →Capex largely internally funded through working capital efficiency without current debt borrowing, with bank lines available if needed at repo-linked rates. (Page 18)
  • →New facility in specialty chemicals at Dahej expected to be ready by H1 FY '28, part of integrated expansion strategy. (Page 4)
  • →Focus on brownfield expansion with new capacities, not just debottlenecking. (Page 8)

How does NOCIL rank vs peers in Chemicals & Petrochemicals?

Pro feature
1NOCIL
Rev 3
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does NOCIL rank in Chemicals & Petrochemicals?

Compare NOCIL against every Chemicals & Petrochemicals company (Q4 FY26) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Other quarters — NOCIL

Q1 FY27Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
NOCIL full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What NOCIL's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q1 FY26 earnings call analysis →
  • Q3 FY26 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Fineotex Chemical Ltd (Q1 FY27)

    INR 1,000 crores in FY'26. Key concall takeaways from Fineotex Chemical Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Tanfac Inds. (Q1 FY27)

    Around 80% to 85% of the solar grade DHF plant capacity is contracted. Key concall takeaways from Tanfac Inds.'s Q1 FY27 earnings call — and how it ranks…

  • Epigral (Q1 FY27)

    Profit after tax (PAT) grew 25% in Q1 FY27 compared to Q1 FY26, reflecting resilience despite a challenging environment. Key concall takeaways from Epigral's…

  • S H Kelkar & Company Ltd (Q1 FY27)

    15 crore). Key concall takeaways from S H Kelkar & Company Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF